Indicators of the quality of life in women with Graves’ disease after radioactive iodine treatment

Abstract

Background. The purpose of the research was to evaluate the quality of life in women with Graves’ disease after radioactive iodine therapy. Materials and methods. We have exa­mined 79 women with Graves’ disease after radioactive iodine treatment. The first group included 23 patients in euthyroid state, the second one — 56 women with hypothyroidism. The control group consisted of 15 women without thyroid patho­logy. Results. Women with Graves’ disease had a deterioration in the quality of life manifested by low indexes of both physical (by 30.3 %) and psychological (by 26.6 %) components of health. Conclusions. After radioactive iodine therapy, there was a significant improvement in the quality of life in women with Graves’ disease, and the total physical component increased by 38.2 %, psychological — by 33.4 %. Before treatment, the qua­lity of life of women with Graves’ disease was significantly lower compared to the control group.

Authors and Affiliations

U. Z. Mirzaeva, Kh. R. Gulyamova

Keywords

Related Articles

Laboratory and instrumental criteria for assessing the persistence of primary hyperparathyroidism within the first day after surgery. Retrospective assessment of risk

Background. The variability of laboratory results leads to an in-depth study of the past medical history and clinical picture, as well as diagnostic procedures to detect parathyroid glands with altered functional activit...

Combined Pathogenetic Therapy of Diabetic Distal Neuropathy

The data on the efficacy and safety of combined pathogenetic therapy in the treatment of distal neuropathy in diabetic patients are presented. There has been demonstrated a positive clinical effect in the combined use of...

Download PDF file
  • EP ID EP299505
  • DOI 10.22141/2224-0721.14.2.2018.130561
  • Views 87
  • Downloads 0

How To Cite

U. Z. Mirzaeva, Kh. R. Gulyamova (2018). Indicators of the quality of life in women with Graves’ disease after radioactive iodine treatment. Міжнародний ендокринологічний журнал, 14(2), 158-162. https://europub.co.uk/articles/-A-299505